New pill aims to slow blinding eye disease
Disease control
Completed
This study tested whether a daily capsule called ALK-001 could slow the progression of geographic atrophy, a severe form of age-related macular degeneration that causes permanent vision loss. About 300 people with this condition were randomly assigned to receive either the study …
Phase: PHASE2, PHASE3 • Sponsor: Alkeus Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC